Evidence map›Paper›PMID 36412679›Full record

ArticleTomography (Ann Arbor, Mich.)2022

Association of True Positivity with Serum Prostate-Specific Antigen Levels and Other Clinical Factors in Indeterminate PSMA-RADS-3A Lesions Identified on

Tushar Garg, Rudolf A Werner, Hyun Woo Chung, Wajahat Khatri, Kenneth J Pienta, Martin G Pomper, Michael A Gorin, Elie Saad, Steven P Rowe

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Tomography (Ann Arbor, Mich.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Tushar GargThe Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.ORCID 0000-0002-5964-6354
Rudolf A WernerDepartment of Nuclear Medicine, University Hospital Würzbürg, 97080 Würzburg, Germany.
Hyun Woo ChungDepartment of Nuclear Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul 05030, Korea.ORCID 0000-0003-4167-3060
Wajahat KhatriDepartment of Radiology, Harlem Hospital, New York, NY 10037, USA.ORCID 0000-0002-3019-2192
Kenneth J PientaDepartment of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.ORCID 0000-0002-4138-2186
Martin G PomperThe Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.ORCID 0000-0001-6753-3010
Michael A GorinThe Milton and Carroll Petrie Department of Urology, Mount Sinai Health System, New York, NY 10029, USA.
Elie SaadThe Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
Steven P RoweThe Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.ORCID 0000-0003-2897-4694
Johns Hopkins University · USHarlem Hospital Center · USKonkuk University Medical Center · KRMount Sinai Health System · USUniversitätsklinikum Würzburg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The use of prostate-specific membrane antigen targeted PET imaging for the evaluation of prostate cancer has increased significantly in the last couple of decades. When evaluating these imaging findings based on the PSMA reporting and data system version 1.0, which categorize lesions based on their likelihood of prostate cancer involvement, PSMA-RADS-3A lesions are commonly seen, which are indeterminate for the presence of disease. A total of 28 patients with 171 PSMA-RADS-3A lesions on

Indexed as

Positron Emission Tomography Computed TomographyProstatic NeoplasmsAgedAged, 80 and overHumansMaleMiddle AgedNeoplasm GradingNeoplasm Recurrence, LocalProstate-Specific AntigenProstate-Specific Antigen18F-DCFPyL PET/CTGleason scoreprostate cancerprostate-specific antigenPSMA-RADS

Identifiers

PMID36412679
PMCPMC9680499
OpenAlexW4307632817

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.